Alzheimer's research to get $400 million boost in Senate bill

The Senate Appropriations Committee plans to propose a $400 million increase in funding for Alzheimer’s research at the National Institutes of Health (NIH), according to the Alzheimer’s Association. 


Alzheimer’s has drawn growing bipartisan concern over the sharply growing costs of caring for people with the disease. 

Finding a treatment or cure for the disease could save money in the long term, argue advocates for increased NIH funding, such as former Speaker Newt Gingrich (R-Ga.).

The new funding comes as part of a bipartisan push from Sens. Roy BluntRoy Dean BluntGOP group calls on Republican senators to stand up to McConnell on election security in new ads Ex-CIA chief worries campaigns falling short on cybersecurity GOP group targets McConnell over election security bills in new ad MORE (R-Mo.) and Patty MurrayPatricia (Patty) Lynn MurrayOvernight Health Care: Planned Parenthood to leave federal family planning program absent court action | Democrats demand Trump withdraw rule on transgender health | Cummings, Sanders investigate three drug companies for 'obstructing' probe Democrats demand Trump officials withdraw rule on transgender health The Hill's Morning Report - Progressives, centrists clash in lively Democratic debate MORE (D-Wash.) to increase NIH funding, the group said. 

The $400 million increase comes on top of the current $991 million in NIH funding for Alzheimer’s. The boost puts the Alzheimer’s Association more than halfway toward its goal of $2 billion per year in funding. 

“If signed into law, today’s funding increase will mark an important milestone in Alzheimer’s research - bringing us past the halfway mark toward the funding level experts agree is necessary to end this epidemic,” Robert Egge, Chief Public Policy Officer of the Alzheimer’s Association, said in a statement. 

More than 5 million people in the United States have Alzheimer’s, according to the Association, yet there is no treatment.